Terug
Dagbereik
€ 4,39
€ 4,74
52-Weeksbereik
€ 2,19
€ 8,80
Volume
4.443.866
50D / 200D Gem.
€ 3,98
/
€ 3,43
Vorige Slotkoers
€ 4,27
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,3 | 0,2 |
| P/B | 1,8 | 3,0 |
| ROE % | -60,3 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,1 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -190,45M
PEG of 0,07 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-60,27%
ROIC-56,73%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,09
Current Ratio6,38
Interest Coverage-120,84
Waardering
P/E Ratio
-2,28
Forward P/EN/A
P/B Ratio1,83
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -223,12M |
| ROE | -60,27% | ROA | -67,52% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -190,45M |
| ROIC | -56,73% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 6,38 |
| Interest Coverage | -120,84 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2,28 | Forward P/E | N/A |
| P/B Ratio | 1,83 | P/S Ratio | N/A |
| PEG Ratio | 0,07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -37,48% | ||
| Market Cap | 508,10M | Enterprise Value | 455,42M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -223,12M | -258,75M | -245,60M | -221,86M | -169,07M |
| EPS (Diluted) | -2,01 | -2,73 | -2,92 | -3,26 | -2,68 |
| Gross Profit | -11,03M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -228,52M | -273,21M | -259,66M | -224,34M | -167,25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 330,45M | 527,70M | 566,34M | 551,81M | 497,02M |
| Total Liabilities | 53,23M | 64,47M | 73,77M | 62,12M | 42,30M |
| Shareholders' Equity | 277,22M | 463,23M | 492,57M | 489,69M | 454,72M |
| Total Debt | 24,88M | 25,50M | 25,04M | 22,87M | 22,60M |
| Cash & Equivalents | 77,56M | 163,64M | 55,90M | 140,52M | 232,69M |
| Current Assets | 192,73M | 378,18M | 378,22M | 364,06M | 392,06M |
| Current Liabilities | 30,21M | 40,68M | 48,51M | 39,17M | 22,17M |